Attention medical professionals! Have you ever encountered a patient with upper gastrointestinal bleeding and wondered how to manage their condition effectively? Look no further than the Sengstaken-Blakemore tube, a lifesaving intervention that can stop even the most severe cases of bleeding. In this blog post, we'll dive into the ins and outs of this procedure, including its indications, step-by-step instructions for placement, and potential risks. By the end of this article, you'll have all the information you need to confidently use this powerful tool in your practice. So buckle up and let's get started!
The Sengstaken-Blakemore tube is a medical device that is inserted into the stomach through the mouth. It is used to treat bleeding from esophageal varices, which are abnormally dilated veins in the esophagus. The tube has three Lumens:
1) The balloon lumen is inflated with air or saline to mechanically occlude the varix.
2) The gastric lumen is a drainage tube that decompresses the stomach and prevents vomiting.
3) The esophageal lumen has a one-way valve to prevent aspiration and allow suctioning of gastric contents.
Indications for use of the Sengstaken-Blakemore tube include active bleeding from esophageal varices, as well as tamponade of bleeding varices prior to endoscopic or surgical treatment. The procedure for inserting the Sengstaken-Blakemore tube is as follows:
1) The patient is placed in the supine position with their head elevated at 30 degrees.
2) A nasogastric tube is inserted and passed through the gastroesophageal junction into the stomach.
3) The distal end of the nasogastric tube is then attached to the proximal end of the Sengstaken-Blakemore tube.
4) The balloon on the Sengstaken-Blakemore tube is then inflated with air or saline using a syringe
The Sengstaken-Blakemore tube is a medical device that is inserted into the stomach through the mouth. It is used to treat bleeding from esophageal varices, which are dilated veins in the esophagus. The tube has a balloon at each end, and the balloon at the top is inflated to apply pressure to the bleeding vessel. The balloon at the bottom is inflated to prevent aspiration of gastric contents. Indications for use of the Sengstaken-Blakemore tube include: Active bleeding from esophageal varices, Suspected imminent rupture of esophageal varices, High-risk patients with cirrhosis who are not candidates for surgery or endoscopic treatment. Contraindications for use of the Sengstaken-Blakemore tube include: Gastric outlet obstruction, Cardiac tamponade, Severe pulmonary hypertension.
There are a few things that medical professionals should keep in mind when inserting the Sengstaken-Blakemore tube. First, the tube should be inserted under fluoroscopic guidance to ensure proper placement. Second, the balloon on the tip of the tube should be inflated with air or saline until it is snug against the gastric mucosa; however, care should be taken not to overinflate the balloon, as this can cause gastric wall necrosis. Finally, once the balloon is inflated, the gastric lumen should be suctioned to prevent aspiration.
The Sengstaken-Blakemore tube is a useful procedure to manage and treat oesophageal varices in certain high risk cases. As with any medical procedure, it's important to assess the potential risks of the patient prior to usage and ensure that the correct indications are met before proceeding. By understanding how this tube works, its instructions for use, complications, and contraindications medical professionals will be able to provide safe and effective care for their patients with suspected or confirmed oesophageal varices.
1.
Glioblastoma treatment breakthrough shows promise
2.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
3.
Study suggests exercise could reduce breast cancer recurrence
4.
Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus
5.
Daily physical activity, even at light intensities, linked to lower cancer risk
1.
Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer
2.
Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies
3.
Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia
4.
HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians
5.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation